Form 4: Dawn M. Zier Reports Acquisition of Prestige Consumer Healthcare Stock

Director Dawn M. Zier reports acquiring 2,202 shares of Prestige Consumer Healthcare Inc. stock as part of director compensation.

Summary

• Dawn M. Zier, a director of Prestige Consumer Healthcare Inc., reported a transaction on August 6, 2024.
• Zier acquired 2,202 shares of common stock as part of the issuer's director compensation program.
• These shares were received as restricted stock units, calculated as $150,000 divided by the closing stock price of $68.13 on August 6, 2024.
• The restricted stock units vest on the first anniversary of the grant and will be settled by delivering one share of common stock for each vested unit.
• Following the reported transaction, Zier directly owns 14,439 shares of Prestige Consumer Healthcare Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. There are no indications of significant positive or negative implications.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

The restricted stock units vest on the first anniversary of the grant and will be settled by delivery of common stock upon vesting or certain events such as death, separation, or change in control.

Industry Context

Director compensation in the form of stock options and restricted stock units is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Stock grants to directors are a common practice among publicly traded companies.
• The size of the grant, valued at $150,000, appears to be within the typical range for director compensation at companies of similar size and market capitalization to Prestige Consumer Healthcare.
• Comparable companies such as Church & Dwight and Helen of Troy also utilize stock grants as part of their director compensation packages.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's performance.

Key Dates